Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic profiling in acute myeloid leukaemia--where are we and what is its role in patient management.

British journal of haematology - 1 Feb 2013

Ofran Yishai, Rowe Jacob M

Abstract excerpt

Genetic profiling in acute myeloid leukaemia (AML) is a moving target. Only 4 years ago, AML was re-classified, based on karyotypic abnormalities. However, numerous important new mutations and other genetic abnormalities that were not considered in this classification have been identified. Current cytogenetic-based classification is limited by the substantial number of intermediate-risk patients in whom the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Chromosome Aberrations
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Leukemic

Share to Leukemia, Myeloid, Acute

Share to MicroRNAs

Share to Point-of-Care Systems

Share to Recurrence

Source

Identifiers

PMID: 23240632
DOI: 10.1111/bjh.12135

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic profiling in acute myeloid leukaemia--where are we and what is its role in patient management.PMID 23240632Read ↗

Molecular Genetic Markers in Acute Myeloid LeukemiaSemantic proximity Read ↗

Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy.Semantic proximity Read ↗

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?Semantic proximity Read ↗

Classification and risk assessment in AML: integrating cytogenetics and molecular profilingSemantic proximity Read ↗

Genetic mutations in acute myeloid leukemia that influence clinical decisions.Semantic proximity Read ↗

The changing paradigm of prognostic factors in acute myeloid leukaemia.Semantic proximity Read ↗

Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profilingSemantic proximity Read ↗

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.Semantic proximity Read ↗

Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications.Semantic proximity Read ↗

Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.Semantic proximity Read ↗

Acute Myeloid Leukemia: from Mutation Profiling to Treatment DecisionsSemantic proximity Read ↗

Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.